Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerNPI Medicare & MedicaidEric Westerman
    Ask Trek AI about this page

    Eric Westerman — Billing Profile & Reimbursement Data

    NPI 1538199849 · Englewood, CO · Rheumatology Physician

    Customize your policy alerts

    Sign up for Eric Westerman — Billing Profile & Reimbursement Data policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Eric Westerman is a rheumatology physician provider located in Englewood, Colorado. This profile covers 27 Medicare and 0 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.

    Table of contents

    Progress1 / 9

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Provider details (source: NPPES NPI Registry)

    FieldValue
    Entity TypeIndividual
    OrganizationEric Westerman
    Address701 E Hampden Ave
    CityEnglewood
    StateCO
    ZIP80113
    TaxonomyRheumatology Physician
    NPI EnumeratedJuly 3, 2006

    Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)

    Payer SourceTotal Paid
    Medicare$1.3M
    Medicaid$0

    Key Findings

    This provider's reported payer mix is effectively single‑payer: Total Medicare revenue is $1.3M and Medicaid revenue is none (no Medicaid billing on file). The absence of Medicaid claims indicates the provider's activity is concentrated in the Medicare population with negligible state Medicaid participation.

    Revenue is highly concentrated in a small set of biologic drug J‑codes: the top 3 Medicare codes by revenue (J1745, J3262, J9312) together account for 48.5% of this provider's total Medicare revenue. Individually those codes are J1745 $250.3K (19.3%), J3262 $200.8K (15.5%), and J9312 $177K (13.7%), showing monoclonal antibody administrations are the core revenue drivers.

    The code mix is consistent with an infusion‑oriented rheumatology practice that administers biologic therapies on site: top J‑codes include infliximab (J1745), tocilizumab (J3262), and rituximab (J9312), and additional biologics such as certolizumab (J0717) and abatacept (J0129) also contribute materially. The presence of infusion/chemotherapy administration CPTs (96413, 96415, 96365) alongside multiple J‑codes supports a clinician‑supervised infusion service rather than a visit‑only model.

    Competitive standing across codes is mixed: for the top drug J1745 the provider ranks #93 of 1352 (93th percentile), indicating a comparatively active national position for infliximab, while J3262 and J9312 rank #302 of 618 (51th percentile) and #163 of 317 (48th percentile) respectively and are described as 'typical, unremarkable volume.' In short, the provider is a notable user of infliximab nationally but a more modest participant for several other biologics.

    Several non‑drug services show notably high utilization relative to peers: 99215 (high‑complexity E&M) ranks #2959 of 145531 (98th percentile; notably above typical national volume) and 96415 (add‑on infusion hours) ranks #156 of 4959 (97th percentile; notably above typical national volume). These high percentiles imply above‑average rates of complex outpatient visits and extended infusion management compared with national peers.

    Lower‑intensity office visit volume is limited, reinforcing the specialty/infusion focus: 99213 appears with 20 claims ($1.4K revenue, 0.1% of Medicare revenue) and ranks #399623 of 457151 (11th percentile), a low relative standing. The combination of concentrated drug revenue and fewer low‑level E&M claims aligns with a practice model centered on specialty infusion care rather than high‑frequency primary care visits.

    The provider shows long tenure in Medicare billing, with NPI enumeration dated 2006-07-03 (~20 years ago). Coupled with $1.3M in Medicare revenue and sustained biologic infusion activity, this tenure supports the interpretation of an established outpatient rheumatology practice operating a clinician‑supervised infusion service.

    Medicare: Total Revenue Breakdown by CPT/HCPCS Code

    Medicare revenue breakdown by CPT/HCPCS procedure code.

    View: Bar Chart1 / 2

    Medicare: Complete Services Breakdown

    The CPT/HCPCS codes generating the most Medicare revenue for this provider.

    27 rows

    CPT/HCPCS CodeDescriptionClaimsAvg PaidRevenue
    J1745Injection, infliximab, excludes biosimilar, 10 mg10,010$30$250.3K
    J3262Injection, tocilizumab, 1 mg40,160$10$200.8K
    J9312Injection, rituximab, 10 mg3,000$60$177K
    J0717Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)44,000$1$176K
    J0129Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)4,130$30$136.1K
    J0897Injection, denosumab, 1 mg5,760$20$103.7K
    J1602Injection, golimumab, 1 mg, for intravenous use8,020$10$80.2K
    99215The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…420$130$55.5K
    96413Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…340$100$35K
    99490The clinical staff provides services directed by the provider to support and coordinate a patient’s care across multiple disciplines. The patient has two or more chronic conditions that place the…410$50$20.6K

    Showing 1–10 of 27

    Medicare: Competitive Analysis & Benchmarks

    How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 27 CPT/HCPCS codes.

    View: State1 / 2

    Full comparison — all codes billed, vs. state median

    27 rows

    CPT/HCPCS CodeRankProvider CountMedian ClaimsAvg PaidAverage Revenue
    J012923306,280$30$250.4K
    J93126103,000$60$193.6K
    J326272028,180$1$158.6K
    J071751037,200$1$134.2K
    J17452403,180$30$110.6K
    J160213208,100$10$108.9K
    J0897261402,580$20$68.8K
    9641326140130$100$19.7K
    992143,2548,16080$80$11.3K
    9636569170100$50$9.5K

    Showing 1–10 of 27

    Related Providers

    Other providers that share a Tax Identification Number (TIN) with Eric Westerman, ranked by combined Medicare and Medicaid revenue.

    ProviderStateTaxonomyMedicare RevenueMedicaid Revenue
    Michael SmithCORheumatology Physician$2M$0
    Anita ZachariahINRheumatology Physician$1.3M$0
    Robert SpencerCORheumatology Physician$1.1M$0
    Cherie ReichartCORheumatology Physician$1.1M$0
    Leslie RoseCORheumatology Physician$663.4K$0
    Daniel ErhardtCORheumatology Physician$547.9K$0
    James SingletonCORheumatology Physician$241.6K$0
    Mark JerankoCORheumatology Physician$219.8K$0

    Nearby Providers

    Other providers in the same ZIP code as Eric Westerman, ranked by combined Medicare and Medicaid revenue.

    ProviderStateTaxonomyMedicare RevenueMedicaid Revenue
    Hca Healthone LLCCOGeneral Acute Care Hospital$0$19.6M
    Marion Health Associates, Inc.COAssisted Living Facility$0$5.1M
    Carepoint Emergency Medicine, PLLCCOEmergency Medicine Physician$0$4.1M
    Novamed Surgery Center Of Denver LLCCOAmbulatory Surgical Clinic/Center$2M$248.7K
    Evoke Medical Care LLCCOCardiology Technician$2M$190.1K
    Christopher BentonCOHematology & Oncology Physician$1.8M$0
    Healthone Ridge View Endoscopy Center, LLCCOAmbulatory Surgical Clinic/Center$695.4K$114.4K
    James TwedeCODermatology Physician$750.3K$0
    Amanda ParkerCOSurgery Physician$692.9K$0
    Cher, LLCCODiagnostic Radiology Physician$198.1K$397.7K

    Frequently Asked Questions

    References

    1. 1.Medicare Physician & Other Practitioner by Provider and Service. CMS.gov.Provider-level Medicare Part B utilization and payment data.
    2. 2.NPPES NPI Registry. CMS.gov.National Provider Identifier registry used for provider enumeration and taxonomy metadata.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    Medicare Revenue by CPT/HCPCS Code
    Claims Volume vs. Colorado Distribution
    Eric Westerman — 3 of 25 codes billed far more than typical (above p95)
    p5–p95 (all providers)p25–p75MedianThis providerOutlier
    Rank Distribution — Colorado